Biblio Discovery — Demo Discovery Service

26 results for "Ali Javaheri"

Showing 21–26 · 0.04 seconds · RSS

  1. Journal Article

    Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

    Mohammad Abdel Jawad; Remo H. M. Furtado; Russell Esterline et al.

    Cardiovascular Diabetology, Vol. 24 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Although several previous studies tested SGLT2 inhibitors in the setting of an acute, non-cardiovascular illness, detailed information on their efficacy and safety among participants with and without type 2 diabetes (T2D) from double-blind randomized trials is lacking. In this…

  2. Journal Article

    Prognostic Significance and Biologic Associations of Senescence‐Associated Secretory Phenotype Biomarkers in Heart Failure

    Oday Salman; Payman Zamani; Lei Zhao et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 13 No. 17 · 2024 · English · DOAJ Scopus

    Background The role of cellular senescence in human heart failure (HF) remains unclear. The senescence‐associated secretory phenotype (SASP) is composed of proteins released by senescent cells. We assessed the prognostic significance and biologic pathways associated with the SASP in human HF using…

  3. Journal Article

    Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction

    Corinne Carland; Lei Zhao; Oday Salman et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 13 No. 9 · 2024 · English · DOAJ Scopus

    Background Although several studies have addressed plasma proteomics in heart failure with preserved ejection fraction, limited data are available on the prognostic value of urinary proteomics. The objective of our study was to identify urinary proteins/peptides associated with death and heart…

  4. Journal Article

    Proteomic Associations of Adverse Outcomes in Human Heart Failure

    Marie‐Joe Dib; Michael G. Levin; Lei Zhao et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 13 No. 5 · 2024 · English · DOAJ Scopus

    Background Identifying novel molecular drivers of disease progression in heart failure (HF) is a high‐priority goal that may provide new therapeutic targets to improve patient outcomes. The authors investigated the relationship between plasma proteins and adverse outcomes in HF and their putative…

  5. Journal Article

    Proteome-Wide Genetic Investigation of Large Artery Stiffness

    Marie-Joe Dib, PhD; Joe David Azzo, MD; Lei Zhao, MD, PhD et al.

    JACC: Basic to Translational Science, Vol. 9 No. 10 · 2024 · English · DOAJ Scopus

    Summary: The molecular mechanisms contributing to large artery stiffness (LAS) are not fully understood. The aim of this study was to investigate the association between circulating plasma proteins and LAS using complementary proteomic and genomic analyses. A total of 106 proteins associated with…

  6. Journal Article

    Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19

    Raquel S. Da Cruz; Heather L. Teague; Marcos J. Ramos-Benitez et al.

    Critical Care Explorations, Vol. 8 No. 7 · 2026 · English · DOAJ Scopus

    OBJECTIVES:. Understanding the mechanistic impact of fostamatinib, a spleen tyrosine kinase inhibitor, in severe COVID-19 using biomarkers associated with disease severity is crucial for the development of host-directed therapeutics. We analyzed samples from a randomized clinical trial to…